🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Primary Bilary Cirrhosis (PBC)

Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis NCT05751967Phase 37 sites📍 Lanzhou📍 Guangzhou📍 Nanjing Xijing Hospital of Digestive Diseases · Tests: Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With Ursodeoxycholic Acid Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy NCT07556913n/a1 site📍 Wilmington Ipsen · Tests: Elafibranor Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) NCT06365424Phase 2, Phase 31 site📍 Xi'an Xijing Hospital of Digestive Diseases · Tests: Fenofibrate, UDCA Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis NCT06051617Phase 3217 sites📍 Birmingham📍 Phoenix📍 Lancaster Gilead Sciences · Tests: Seladelpar, Placebo Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy NCT07424677Phase 31 site📍 Lakewood Rch Zydus Therapeutics Inc. · Tests: Saroglitazar Magnesium 1 mg, Placebo Detection Program for Patients With Primary Biliary Cholangitis Lost in the System NCT05919433n/a1 site📍 Terrassa Hospital Mutua de Terrassa Biochemical Response and Clinical Outcomes in Patients With PBC NCT07449793n/a1 site📍 Shanghai RenJi Hospital · Tests: Only observation Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy NCT07296458Phase 31 site📍 Xi'an Xijing Hospital of Digestive Diseases · Tests: Fenofibrate, UDCA (Ursodeoxycholic acid) Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP) NCT07205874n/a1 site📍 Madrid Hospital Universitario La Paz Canadian Network for Autoimmune Liver Disease NCT03569826n/a15 sites📍 Calgary📍 Edmonton📍 Vancouver University Health Network, Toronto · Tests: Observational; no intervention LEOPARD Prospective Validation Cohort 1 NCT06723275n/a8 sites📍 Ghent📍 Clichy📍 Créteil Assistance Publique - Hôpitaux de Paris · Tests: Standardized assessments, guided tumor biopsy and biobanking, Standardized assessments and biobanking Swiss Primary Biliary Cholangitis Cohort Study NCT03146910n/a13 sites📍 Lugano📍 Basel📍 Bern Fondazione Epatocentro Ticino Biobank for Cholestatic Liver Diseases. NCT03445585n/a1 site📍 Rochester Mayo Clinic RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis NCT07161245NA1 site📍 Barcelona Hospital Clinic of Barcelona · Tests: Multimodal prehabilitation, standard of care PBC Long-term Outcomes Study NCT07149675n/a1 site📍 Beijing Beijing Friendship Hospital A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA NCT07282353Phase 342 sites📍 Hefei📍 Hefei📍 Hefei Cascade Pharmaceuticals, Inc · Tests: 2mg CS0159, Placebo sCD163 in PBC Patients - Assessment of Treatment Response NCT02931513n/a1 site📍 Aarhus C University of Aarhus · Tests: Blood samples, Fibroscan, Questionnaires, Liver biopsy National Database on Primary Biliary Cholangitis NCT05151809n/a55 sites📍 Ancona📍 Bari📍 Bergamo University of Milano Bicocca · Tests: Clinical information Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis NCT05749822Phase 2, Phase 312 sites📍 Beijing📍 Guangzhou📍 Zhengzhou Xijing Hospital of Digestive Diseases · Tests: Fenofibrate 200mg, Placebo, UDCA Austrian PBC Registry NCT07598669n/a11 sites📍 Klagenfurt📍 Sankt Pölten📍 Salzburg Medical University of Vienna An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site📍 Hvidovre University of Copenhagen A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis NCT06016842Phase 3198 sites📍 Tucson📍 Little Rock📍 Coronado Ipsen · Tests: Elafibranor, Matched 80 mg placebo Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease NCT06825559Phase 11 site📍 Indianapolis Zydus Therapeutics Inc. · Tests: Saroglitazar Magnesium 1 mg Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study NCT06755541Phase 31 site📍 Xi'an Xijing Hospital of Digestive Diseases · Tests: Fenofibrate in Combination With Ursodeoxycholic Acid Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome NCT06519162n/a1 site📍 Daejeon Chungnam National University Hospital Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai) NCT06767605n/a1 site📍 Barcelona Asociación Española para el Estudio del Hígado LEOPARD Training and Validation Data Collection Study NCT06675604n/a53 sites📍 Vienna📍 Brussels📍 Ghent Assistance Publique - Hôpitaux de Paris Clinical Research of Tapering UDCA in PBC Patients With a Complete Response NCT04650243Phase 41 site📍 Beijing Peking Union Medical College Hospital · Tests: ursodeoxycholic acid Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes NCT07216235Phase 33 sites📍 Marietta📍 Indianapolis📍 Houston Zydus Therapeutics Inc. · Tests: Saroglitazar magnesium 1 mg, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy